BCI
GILD icon

Brinker Capital Investments’s Gilead Sciences GILD Stock Holding History

Brinker Capital Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.57M Sell
68,638
-40,819
-37% -$5.72M 0.08% 216
2025
Q4 		$13.4M Buy
109,457
+9,136
+9% +$1.11M 0.1% 176
2025
Q3 		$11.1M Buy
100,321
+8,843
+10% +$1.01M 0.09% 206
2025
Q2 		$10.1M Buy
91,478
+27,018
+42% +$2.88M 0.09% 213
2025
Q1 		$7.22M Sell
64,460
-25,566
-28% -$2.64M 0.07% 266
2024
Q4 		$8.32M Buy
90,026
+3,224
+4% +$290K 0.08% 224
2024
Q3 		$7.28M Buy
86,802
+634
+0.7% +$48.4K 0.07% 263
2024
Q2 		$5.91M Sell
86,168
-1,399
-2% -$93.4K 0.06% 277
2024
Q1 		$6.41M Sell
87,567
-7,858
-8% -$604K 0.07% 275
2023
Q4 		$8.01M Sell
95,425
-16,332
-15% -$1.27M 0.09% 210
2023
Q3 		$8.38M Sell
111,757
-6,496
-5% -$500K 0.1% 195
2023
Q2 		$9.11M Sell
118,253
-2,151
-2% -$172K 0.1% 206
2023
Q1 		$9.99M Buy
120,404
+38,555
+47% +$3.19M 0.12% 156
2022
Q4 		$7.03M Sell
81,849
-8,713
-10% -$690K 0.14% 155
2022
Q3 		$5.59M Buy
90,562
+1,046
+1% +$66K 0.12% 173
2022
Q2 		$5.53M Buy
89,516
+33,675
+60% +$2.08M 0.1% 190
2022
Q1 		$3.32M Sell
55,841
-11,956
-18% -$764K 0.05% 356
2021
Q4 		$4.92M Buy
67,797
+7,085
+12% +$488K 0.07% 273
2021
Q3 		$4.18M Hold
60,712
– – 0.07% 308
2021
Q2 		$4.18M Buy
60,712
+10,071
+20% +$672K 0.06% 354
2021
Q1 		$3.27M Sell
50,641
-9,314
-16% -$601K 0.05% 363
2020
Q4 		$3.49M Buy
59,955
+13,898
+30% +$839K 0.05% 413
2020
Q3 		$2.91M Buy
+46,057
New +$3.19M 0.05% 356
2019
Q3 		– Sell
-3,093
Closed -$209K – 828
2019
Q2 		$209K Buy
3,093
+2,920
+1,688% +$192K 0.01% 380
2019
Q1 		$11K Buy
+173
New +$11.5K ﹤0.01% 622
2017
Q4 		– Sell
-74
Closed -$6K – 545
2017
Q3 		$6K Buy
74
+59
+393% +$4.51K ﹤0.01% 467
2017
Q2 		$1K Sell
15
-235
-94% -$15.6K ﹤0.01% 471
2017
Q1 		$17K Hold
250
– – ﹤0.01% 363
2016
Q4 		$18K Buy
250
+244
+4,067% +$18.1K ﹤0.01% 350
2016
Q3 		$0 Buy
+6
New +$487 ﹤0.01% 547
2016
Q1 		– Sell
-22
Closed -$2K – 522
2015
Q4 		$2K Buy
22
+18
+450% +$1.87K ﹤0.01% 463
2015
Q3 		$0 Buy
+4
New +$444 ﹤0.01% 477
2015
Q2 		– Sell
-298
Closed -$29K – 425
2015
Q1 		$29K Buy
298
+198
+198% +$20.1K ﹤0.01% 324
2014
Q4 		$9K Hold
100
– – ﹤0.01% 365
2014
Q3 		$11K Hold
100
– – ﹤0.01% 322
2014
Q2 		$8K Hold
100
– – ﹤0.01% 341
2014
Q1 		$7K Hold
100
– – ﹤0.01% 360
2013
Q4 		$8K Hold
100
– – ﹤0.01% 333
2013
Q3 		$6K Buy
+100
New +$5.98K ﹤0.01% 345

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Brinker Capital Investments's GILD Position: Q1 2026 in Review

Brinker Capital Investments reduced its Gilead Sciences (GILD) stake by 37% in Q1 2026, selling an estimated $5.72M and leaving 68,638 shares worth $9.57M. The position accounts for 0.08% of the portfolio, ranked #216.

Brinker Capital Investments first reported a position in GILD in Q3 2013 and has held it in 39 quarters since. The position peaked at $13.4M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Brinker Capital Investments held 68,638 shares of Gilead Sciences worth $9.57M as of Q1 2026.
  • Brinker Capital Investments sold 40,819 Gilead Sciences shares in Q1 2026, an estimated $5.72M.
  • Gilead Sciences made up 0.08% of Brinker Capital Investments's portfolio in Q1 2026, its #216 holding.
  • Brinker Capital Investments first reported a position in Gilead Sciences in Q3 2013 and has held it in 39 quarters since.
  • Brinker Capital Investments's Gilead Sciences position peaked at $13.4M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.